Skip to main content

Advertisement

ADVERTISEMENT

News

Deep View - Spectral AI

https://www.globenewswire.com/news-release/2024/09/24/2952072/0/en/Spectral-AI-Achieves-25-Patient-Enrollment-at-Emergency-Departments-for-U-S-Burn-Pivotal-Study-and-Adds-Two-New-Clinical-Trial-Sites.html

Spectral AI announces it has achieved 25% of patient enrollment at emergency depts (EDs) for its US Burns Pivotal Study and added 2 more clinical sites, expanding to 11 ED facilities. The company plans to pursue a De Novo submission for DeepView as a Class II medical device in Q225.

Advertisement

Advertisement

Advertisement